- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03415568
Effects of MCDG Oil on Postprandial Lipid Metabolism
January 29, 2018 updated by: Jong Ho Lee, Yonsei University
The Effects of Functional Edible Oil (MCDG) on Reducing Body Fat of Overweight or Obesity Subjects (Part.2)
It is well known that medium chain triglycerides (MCTs) and diacylglycerols (DGs) have effects on lowering circulating triglycerides (TGs).
In this study, the mixture of MCTs and DGs (MCDGs) examined whether it has beneficial effects on postprandial lipids metabolism compared to long-chain triglycerides (TGs).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A randomized, double-blinded, controlled, cross-over trial was conducted to verify the effects of MCDGs.
Twenty-eight healthy male and female subjects aged 21-29 years with normal body weight [18.5 kg/m^2 ≤ body mass index (BMI) < 25 kg/m^2] were recruited.
The subjects visited the research site twice over with a seven-day interval after an overnight fast at least 12 hr.
On the first visit, the participants were randomly assigned to consume a test or placebo product [test product: muffins containing MCDG oil (MCDG muffin); placebo product: muffins containing LCT oil (LCT muffin)] and ingested the assigned product.
On the second visit, the participants consumed the other product that they did not eat on the first visit.
On both visit day, the 6-hr meal tolerance test was conducted and started at 8:00 in the morning; venous blood samples were collected before (0 hr) and after ingestion (2, 3, 4, and 6 hr) of the products.
Study Type
Interventional
Enrollment (Actual)
28
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 03722
- Laboratory of Clinical Nutrigenetics/Nutrigenomics, Yonsei University.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 29 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy subjects with normal body weight (18.5 kg/m^2 ≤ body mass index (BMI) < 25 kg/m^2)
Exclusion Criteria:
- history/presence of hypertension, diabetes mellitus, hyperlipidemia, cardiovascular disease, liver disease, gastrointestinal disease, thyroid disease, or any other acute or chronic diseases requiring treatment
- Use of any medication affecting body weight or energy expenditure for 1 month before screening
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
PLACEBO_COMPARATOR: LCT consumption
Muffin that contains 15g of long-chain triglyceride (LCT) oils were provided to conduct 6-h meal tolerance test.
|
LCT muffin was provided to the study participants.
The LCT muffin was consumed within 15 min, and then 6-h meal tolerance test was conducted.
The muffin had approximately 465 kcal, 8.36 g of protein, 17.24 g of fat, and 69.0 g of carbohydrate; among the 17.24g of fat, 15g of fat was LCT.
|
EXPERIMENTAL: MCDG consumption
Muffin that contains 15g of the mixture of medium-chain triglyceride and diacylglycerol (MCDG) oils were provided to conduct 6-h meal tolerance test.
|
MCDG muffin was provided to the study participants.
The MCDG muffin was consumed within 15 min, and then 6-h meal tolerance test was conducted.
The muffin had approximately 465 kcal, 8.36 g of protein, 17.24 g of fat, and 69.0 g of carbohydrate; among the 17.24g of fat, 15g of fat was MCDG.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Triglyceride levels
Time Frame: 6 hours
|
Triglyceride level differences during the 6-hr meal tolerance test between LCT and MCDG muffins intake
|
6 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The areas under the curve (AUC) of triglycerides
Time Frame: 1 day of second visit (after finishing cross-over trial)
|
Triglyceride AUC differences between LCT and MCDG muffins intake
|
1 day of second visit (after finishing cross-over trial)
|
Triglyceride maximum concentration time
Time Frame: 1 day of second visit (after finishing cross-over trial)
|
The time when triglyceride peaks maximum concentration during the 6-h meal tolerance test
|
1 day of second visit (after finishing cross-over trial)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
June 30, 2017
Primary Completion (ACTUAL)
July 28, 2017
Study Completion (ACTUAL)
July 28, 2017
Study Registration Dates
First Submitted
January 15, 2018
First Submitted That Met QC Criteria
January 29, 2018
First Posted (ACTUAL)
January 30, 2018
Study Record Updates
Last Update Posted (ACTUAL)
January 30, 2018
Last Update Submitted That Met QC Criteria
January 29, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- DOP_OFTT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hyperlipidemias
-
University of BolognaNot yet recruiting
-
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co....Not yet recruiting
-
Meir Medical CenterNot yet recruitingHypertriglyceridemiaIsrael
-
Novartis PharmaceuticalsRecruitingHypercholesterolemiaUnited States, Hungary, Mexico, Germany, Colombia
-
Esperion Therapeutics, Inc.RecruitingHypercholesterolemiaUnited States, Spain, Denmark, Canada, Netherlands, Germany
-
Jena University HospitalCharite University, Berlin, Germany; Ruhr University of Bochum; Technische Universität... and other collaboratorsRecruiting
-
Kowa Company, Ltd.Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
University Health Network, TorontoRecruitingHyperlipidemiasCanada
-
Organon and CoCompleted
Clinical Trials on LCT oil
-
National University Hospital, SingaporeWilmar InternationalEnrolling by invitationNAFLD | Non-Alcoholic Fatty Liver Disease | Non-Alcoholic SteatohepatitisSingapore
-
University Hospitals, LeicesterCompletedAssess Effect of Omega-3 Fish Oil in Patients With Severe Acute PancreatitisUnited Kingdom
-
B. Braun Melsungen AGCompleted
-
University of AlbertaStollery Children's Hospital FoundationCompletedInflammation | Cardiac Surgical ProceduresCanada
-
Fundació Institut de Recerca de l'Hospital de la...UnknownSevere Acute PancreatitisSpain
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São Paulo; Conselho Nacional de...Completed
-
Wei ZhouUnknownLiver Tumor | Gastric Tumor | Pancreatic TumorChina
-
Zipper Urogynecology AssociatesUnknown
-
B. Braun Medical SATerminated
-
University of MiamiLiteCure LLCWithdrawn